Trial Profile
A pilot phase II trial of celecoxib in patients with grade 2 or 3 endometrioid-type, clear cell, and papillary serous uterine cancers.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Uterine cancer
- Focus Therapeutic Use
- 23 Apr 2012 Actual end date (1 Mar 2004) added as reported by ClinicalTrials.gov.
- 23 Apr 2012 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 23 Jul 2007 The expected completion date for this trial is now 1 Sep 2008.